ArticleLeukemia & lymphoma2014

RUNX1-ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development.

Russell C DeKelver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.